Find similar content

Source channel @githubtrending · Post #14817 · Jun 11

#python#asr#captions#cli#python#subtitle#subtitles#transcript#transcripts#translating_transcripts#youtube#youtube_api#youtube_asr#youtube_captions#youtube_subtitles#youtube_transcript#youtube_transcripts#youtube_video The YouTube Transcript API is a tool that helps you get the text from YouTube videos. It's fast and easy to use, saving you time compared to watching the whole video. You can use it to make subtitles, translate text, and even analyze what's being said in videos. This is helpful for content creators who want to make their videos more accessible and for researchers who need to study video content quickly. It also supports multiple languages, making it useful for a wide range of users. https://github.com/jdepoix/youtube-transcript-api

Hashtags

#python #asr #captions #cli #subtitle #subtitles #transcript #transcripts #translating_transcripts #youtube #youtube_api #youtube_asr #youtube_captions #youtube_subtitles #youtube_transcript #youtube_transcripts #youtube_video

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment